Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome

• Published in: Frontiers in endocrinology (Lausanne) 2021-05, Vol.12, p.604215-604215
• Main Authors: Velazquez, Mariela Edith, Millan, Andrea L, Rojo, Mailén, Abruzzese, Giselle Adriana, Cocucci, Silvina Ema, Iglesias Molli, Andrea Elena, Frechtel, Gustavo Daniel, Motta, Alicia Beatriz, Cerrone, Gloria Edith
• Format: Article
• Language: English
• Subjects: Adult; Argentina - epidemiology; Body Mass Index; Case-Control Studies; Endocrinology; Female; Humans; hyperandrogenism; Hyperandrogenism - complications; Hyperandrogenism - epidemiology; Hyperandrogenism - genetics; metabolic and endocrine disorders; obesity; Obesity - complications; Obesity - epidemiology; Obesity - genetics; polycystic ovary syndrome; Polycystic Ovary Syndrome - complications; Polycystic Ovary Syndrome - epidemiology; Polycystic Ovary Syndrome - genetics; Retrospective Studies; Telomere - chemistry; Telomere - metabolism; Telomere Homeostasis - physiology; telomere length; Testosterone - blood
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2021.604215

Polycystic Ovary Syndrome (PCOS) often present metabolic disorders and hyperandrogenism (HA), facts that may influence the telomere length (TL). To compare the absolute TL (aTL) between women with PCOS and control women, and their association with the presence of obesity and HA parameters. The PCOS group included 170 unrelated women outpatients and the control group, 64 unrelated donor women. Anthropometric, biochemical-clinical parameters and androgen profile were determined. The PCOS patients were divided accordingly to the presence of obesity and androgenic condition. The aTL was determined from peripheral blood leukocytes by Real Time quantitative PCR. Women with PCOS exhibited a significantly longer aTL than controls after age adjustment (p=0.001). A stepwise multivariate linear regression in PCOS women, showed that WC (waist circumference) contributed negatively (b=-0.17) while testosterone levels contributed positively (b=7.24) to aTL. The non-Obese PCOS (noOB-PCOS) presented the longest aTL when compared to controls (p=0.001). Meanwhile, the aTL was significantly higher in the hyperandrogenic PCOS phenotype (HA-PCOS) than in the controls (p=0.001) and non hyperandrogenic PCOS phenotype (NHA-PCOS) (p=0.04). Interestingly, when considering obesity and HA parameters in PCOS, HA exerts the major effect over the aTL as non-obese HA exhibited the lengthiest aTL (23.9 ± 13.13 Kbp). Conversely, the obese NHA patients showed the shortest aTL (16.5 ± 10.59 Kbp). Whilst a shorter aTL could be related to the presence of obesity, a longer aTL would be associated with HA phenotype. These findings suggest a balance between the effect produced by the different metabolic and hormonal components, in PCOS women.